首页> 美国卫生研究院文献>other >Lipophilic indocarbocyanine conjugates for efficient incorporation of enzymes antibodies and small molecules into biological membranes
【2h】

Lipophilic indocarbocyanine conjugates for efficient incorporation of enzymes antibodies and small molecules into biological membranes

机译:亲脂性吲哚碳花菁偶联物可有效地将酶抗体和小分子掺入生物膜

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Decoration of cell membranes with biomolecules, targeting ligands and imaging agents is an emerging strategy to improve functionality of cell-based therapies. Compared to covalent (e.g., click) chemistry or genetic expression on the cell surface, lipid painting (i.e., incorporation of lipid-conjugated molecules into the cell bilayer) is a fast, non-damaging and less expensive approach. Previous studies demonstrated excellent incorporation and retention of distearyl indocarbocyanine dye DiI in membranes of cells in vitro and in vivo. In order to exploit the membrane stability of DiI, we synthesized an amino-DiI derivative, to which we subsequently conjugated an antibody (cetuximab), an enzyme (superoxide dismutase), and a small molecule (DyLight 800). Red blood cells have long been used as drug delivery vehicles so they were utilized as a model to study the incorporation of DiI conjugates in the plasma membrane. All the DiI constructs demonstrated fast and efficient ex vivo incorporation in the membrane of mouse RBCs, resulting in millions of exogenous molecules per RBC. Following an intravenous injection into mice, the molecules were detected on circulating RBCs for several days. DiI anchored molecules showed longer residence time in blood and significantly higher area under the curve (AUC) compared to free non-conjugated molecules. Thus, cetuximab, SOD and DyLight painted on RBC showed 5.5-fold, 6.5-fold and 78-fold increase in the AUC, respectively, compared to the non-modified molecules. Lipophilic indocarbocyanine anchors are a promising technology for incorporation of biomolecules and small molecules into biological membranes for in vivo applications.
机译:用生物分子,靶向配体和显像剂修饰细胞膜是提高基于细胞的疗法功能的新兴策略。与细胞表面上的共价(例如点击)化学或遗传表达相比,脂质涂漆(即将脂质缀合的分子掺入细胞双层)是一种快速,无损且成本较低的方法。先前的研究表明,在体外和体内,二硬脂基吲哚并花菁染料DiI在细胞膜中具有出色的结合和保留能力。为了利用DiI的膜稳定性,我们合成了一个氨基DiI衍生物,随后将其与抗体(西妥昔单抗),一种酶(超氧化物歧化酶)和一个小分子(DyLight 800)缀合。红细胞长期以来一直被用作药物输送媒介,因此它们被用作研究DiI偶联物在质膜中掺入的模型。所有的DiI构建体都证明了在小鼠RBC膜中快速有效地离体结合,从而每个RBC产生数百万个外源分子。向小鼠静脉内注射后,在循环的RBC上检测了几天的分子。与游离的非共轭分子相比,锚定的DiI分子在血液中的停留时间更长,曲线下面积(AUC)明显更高。因此,与未修饰的分子相比,涂在RBC上的西妥昔单抗,SOD和DyLight的AUC分别增加了5.5倍,6.5倍和78倍。亲脂性吲哚并花菁锚是将生物分子和小分子掺入生物膜用于体内应用的有前途的技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号